Glia-mediated gut-brain cytokine signaling couples sleep to intestinal inflammation

Alina Malita,Olga Kubrak,Xiaokang Chen,Takashi Koyama,Elizabeth C. Connolly,Nadja Ahrentløv,Ditte S. Andersen,Michael J. Texada,Kenneth V. Halberg,Kim Rewitz,Malita,A.,Kubrak,O.,Chen,X.,Koyama,T.,Connolly,E. C.,Ahrentloev,N.,Andersen,D. S.,Texada,M. J.,Halberg,K.,Rewitz,K.

DOI: https://doi.org/10.1101/2024.06.25.600726

2024-07-01

bioRxiv

Abstract:Sickness-induced sleep is a behavior conserved across species that promotes recovery from illness, yet the underlying mechanisms are poorly understood. Here, we show that interleukin-6-like cytokine signaling from the Drosophila gut to brain glial cells regulates sleep. Under healthy conditions, this pathway promotes wakefulness. However, elevated gut cytokine signaling in response to oxidative stress - triggered by immune and inflammatory responses in the intestine - induces sleep. The cytokines Unpaired 2 and -3 are upregulated by oxidative stress in enteroendocrine cells and activate JAK-STAT signaling in glial cells, including those of the blood-brain barrier (BBB). This activity maintains elevated sleep during oxidative-stress-induced intestinal disturbances, suggesting that the JAK-STAT pathway in glia inhibits wake-promoting signaling to facilitate sleep-dependent restoration under these conditions. We find that the enteric peptide Allatostatin A (AstA) enhances wakefulness, and during intestinal oxidative stress, gut-derived Unpaired 2/3 inhibits AstA receptor expression in BBB glia, thereby sustaining an elevated sleep state during gut inflammation or illness. Taken together, our work identifies a gut-to-glial communication pathway that couples sleep with intestinal homeostasis and disease, enhancing sleep during intestinal sickness, and contributes to our understanding of how sleep disturbances arise from gastrointestinal disturbances.